This inventor holds 2 USPTO granted patents. Top assignee: Entos Pharmaceuticals Inc.. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2025
Title: Konstantin Stoletov: Innovator in Cancer Treatment
Introduction
Konstantin Stoletov is a prominent inventor based in Edmonton, Canada. He has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of metastatic cancer. With a total of 2 patents, his work is paving the way for innovative medical solutions.
Latest Patents
Stoletov's latest patents focus on methods for diagnosing and treating metastatic cancer. These patents disclose methods that involve detecting or modulating the expression of various genes and microRNAs in biological samples from subjects. The specific genes include Kif3b, ACTB, SRPK1, TM EM 229b, C14orf142, KB-1460A1.5, ACTC1, Nr2f1, KIAA0922, KDELR3, APBA2, miRNA 130b, miRNA 374b, and miRNA 122. These advancements hold promise for improving cancer treatment outcomes.
Career Highlights
Stoletov is currently associated with Entos Pharmaceuticals Inc., where he continues to develop innovative solutions in the medical field. His work is characterized by a commitment to advancing cancer research and improving patient care.
Collaborations
Some of his notable coworkers include John Lewis and Lian Willetts. Their collaborative efforts contribute to the innovative environment at Entos Pharmaceuticals Inc.
Conclusion
Konstantin Stoletov is a dedicated inventor whose work in cancer treatment is making a significant impact. His innovative patents and collaborations are essential in the ongoing fight against metastatic cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile